ARTICLE | Company News
Neurochem, Lundbeck terminate AD deal
October 12, 2001 7:00 AM UTC
The companies ended their 1999 deal in which H. Lundbeck (Copenhagen, Denmark) acquired an exclusive worldwide right to develop and commercialize therapeutics discovered by Neurochem (TSE:NRM) to trea...